Pulmonx (LUNG) Cash & Current Investments (2019 - 2025)

Pulmonx (LUNG) has 7 years of Cash & Current Investments data on file, last reported at $69.8 million in Q4 2025.

• On a quarterly basis, Cash & Current Investments fell 31.27% year-over-year to $69.8 million in Q4 2025; TTM through Dec 2025 was $69.8 million, a 31.27% decrease from a year earlier, with the FY2025 full-year figure at $69.8 million, down 31.27% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $69.8 million, down from $76.5 million in the prior quarter.
• Over the last five years, Cash & Current Investments for LUNG reached as high as $219.1 million in Q1 2021 and fell as low as $69.8 million in Q4 2025.
• Historically, Cash & Current Investments has averaged $136.0 million across 5 years, with a median of $126.1 million in 2023.
• Across the five-year window, Cash & Current Investments surged 1248.85% in 2021 and slumped 31.27% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $180.0 million in 2021, then declined by 21.61% to $141.1 million in 2022, then slipped by 17.03% to $117.1 million in 2023, then fell by 13.34% to $101.5 million in 2024, then slumped by 31.27% to $69.8 million in 2025.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $69.8 million in Q4 2025, $76.5 million in Q3 2025, and $84.2 million in Q2 2025.